Gleneagles Hospital Hong Kong is a multi-specialty private hospital in Wong Chuk Hang, Hong Kong. The 500-bed hospital is a joint venture between Singapore-based Parkway Pantai and Hong Kong-listed NWS Holdings, with The University of Hong Kong being the hospital’s exclusive clinical partner.

There are 500 beds in Gleneagles Hospital HongKong.

During the past decade, Gleneagles Hospital HongKong conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gleneagles Hospital HongKong" #1 collaborator was "Gleneagles Hospital" with 2 trials as a collaborator and "Queen Mary Hospital, Hong Kong" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Gleneagles Hospital HongKong" are "COVID-19" (2 trials), "Cervical Cancer" (2 trials), "Gynecologic Cancer" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Gleneagles Hospital HongKong" in a lesser frequency.

Most popular intervention types in "Gleneagles Hospital HongKong" are "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gynaecological laparoscopic surgery (Sirius System)" (2 trials), "COVID-19 Vaccine (Vero Cell), Inactivated (High-dose)" (1 trials), "COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)" (1 trials) and "COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gleneagles Hospital HongKong" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gleneagles Hospital HongKong". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gleneagles Hospital HongKong, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gleneagles Hospital HongKong, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".